Leukemic Cell Proteomic Profiling in Pediatric AML.

被引:0
|
作者
Nguyen, Nam K. [1 ]
Wu, Huiyun [2 ]
Peng, Junmin [2 ]
Rubnitz, Jeffrey E. [2 ]
Pounds, Stanley [2 ]
Lamba, Jatinder K. [1 ]
机构
[1] Univ Florida, Coll Pharm, Gainesville, FL USA
[2] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2535
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Complete molecular testing in AML.
    Williams, Travis Grant
    Ganguly, Siddhartha
    McGuirk, Joseph
    Male, Heather Jean
    Fleming, Allan
    Aljitawi, Omar Salah
    Abhyankar, Sunil H.
    Lin, Tara L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Abnormalities of proliferation control in AML.
    Preisler, HD
    Venugopal, P
    Shivaraman, S
    Manson, S
    BLOOD, 2000, 96 (11) : 166B - 167B
  • [23] Advances in proteomic profiling of pediatric kidney diseases
    Cummins, Timothy D.
    Korte, Erik A.
    Bhayana, Sagar
    Merchant, Michael L.
    Barati, Michelle T.
    Smoyer, William E.
    Klein, Jon B.
    PEDIATRIC NEPHROLOGY, 2022, 37 (10) : 2255 - 2265
  • [24] Advances in proteomic profiling of pediatric kidney diseases
    Timothy D. Cummins
    Erik A. Korte
    Sagar Bhayana
    Michael L. Merchant
    Michelle T. Barati
    William E. Smoyer
    Jon B. Klein
    Pediatric Nephrology, 2022, 37 : 2255 - 2265
  • [25] Urine proteomic profiling of pediatric nephrotic syndrome
    Mona Khurana
    Avram Z. Traum
    Manuel Aivado
    Meghan P. Wells
    Manuel Guerrero
    Franck Grall
    Towia A. Libermann
    Asher D. Schachter
    Pediatric Nephrology, 2006, 21 : 1257 - 1265
  • [26] Urine proteomic profiling of pediatric nephrotic syndrome
    Khurana, Mona
    Traum, Avram Z.
    Aivado, Manuel
    Wells, Meghan P.
    Guerrero, Manuel
    Grall, Franck
    Libermann, Towia A.
    Schachter, Asher D.
    PEDIATRIC NEPHROLOGY, 2006, 21 (09) : 1257 - 1265
  • [27] Prognostic impact of aberrant t/NK cell marker expression in AML.
    Saste, Abhijit Balkrishna
    Gulati, Rohit
    Kuriakose, Philip
    Inamdar, Kedar
    Karner, Kristin
    Carey, John
    Menon, Madhu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Epigenetic inactivation of miR-9 in EVI1 high pediatric AML.
    Mittal, Nupur
    Li, Liping
    Qian, Zhijian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Targeted toxins are cell-specific modulators of drug resistance in AML.
    Frankel, AE
    Hall, PD
    Safa, AR
    Bhalla, K
    Tagge, EP
    Kreitman, RJ
    BLOOD, 1997, 90 (10) : 807 - 807
  • [30] Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape
    Tracy, Sean, I
    Venkatesh, Hrishi
    Arroyo, Miriam
    Knutson, Todd
    Tilahun, Ashenafi
    Grzywacz, Bartosz
    Farrar, Michael
    BLOOD, 2022, 140 : 6341 - 6342